Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

SpringWorks raises $125mm in Series B round

Executive Summary

SpringWorks Therapeutics Inc. (rare diseases and cancer) raised $125mm through its Series B round led by Perceptive Advisors. New investors Boxer Capital (Tavistock), HBM Healthcare, BVF Partners, Surveyor Capital (Citadel), Samsara BioCapital, ArrowMark Partners, GSK, and Laurion Capital Management were joined by returning backers OrbiMed, Bain Capital, Pfizer Ventures, and LifeArc. Proceeds will advance late-stage projects nirogacestat and PD0325901 towards regulatory approval and commercialization for desmoid tumors and neurofibromatosis type 1-associated plexiform neurofibromas, respectively.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies